Etat de mise en œuvre de la Stratégie régionale pour la promotion de la Médicine traditionnelle E

Premier Sminaire francophone de formation sur les Politiques pharmaceutiquesGenve, 20-24 avril 2009Etat de mise en uvre de la Stratgie rgionale pour la promotion de la Mdicine traditionnelle

EJean-Marie TrapsidaConseiller rgionalGestionnaire du Programme des Mdicaments essentiels

*OMS, Bureau rgional de lAfrique,Division de Dveloppement des Systmes et Services de Sant

Sommaire

1. Introduction;2. Etat de mise de la Stratgie rgionale:Formulation des politiques;Dveloppement de la production locale et conservation des plantes mdicinales;Promotion de la recherche;Droits de proprit intellectuelle et savoir mdical traditionnel;Renforcement des capacits.3. Conclusion


INTRODUCTION (1)

1983 - Rsolution AFR/RC33/R3 de lOMS relative la promotion de la MT et de la pharmacope africaine;

1984 - Rsolution AFR/RC34/R8 de lOMS relative la prparation dune lgislation spcifique sur lexercice de la MT dans le cadre de la lgislation sanitaire nationale;

2000 - la Rsolution AFR/RC50/R3 de lOMS relative la promotion du rle de la MT dans le systme de sant: Stratgie de la Rgion africaine


INTRODUCTION (2)

2001 - la Dclaration du Sommet des Chefs dtat Abuja sur la recherche de la MT pour le traitement du Paludisme, VIH/SIDA, Tuberculose et autres maladies infectieuses comme prioritaire (Avril)

2001 - la Dclaration du Sommet des Chefs dtat Lusaka dsignant la priode 2001-2010: Dcennie de la MT africaine (juillet)

2002 La commission sur les droits des proprit intellectuelle, linnovation et la sant publique tablir par le DG de lOMS

2002 - la Dsignation par lOMS de la journe du 31 aot de chaque anne comme Journe Africaine de la MT et approbation par les Chefs dtat Maputo 2003


Orientations politiques et engagement des Etats membres et de lOMS Adoption of Regional Strategy by RC50Dclaration dAbuja sur la recherche sur les MTs Avril 2001Dclaration sur la dcennie africaine de la MT (2001-2010),Lusaka,Juillet 2001Adoption de la Stratgie globale sur la TRM,2002-2005 par lAMS, GenveMalaria, TB, HIV/AIDS et autresAdoption du Plan daction, Tripoli, 2003WHA56. 31, 2003Comit rgional,Ouagadougou 2000Dclaration Alma Ata, 1978


Stratgie rgionale sur la promotion sur la promotion de la Mdecine traditionnelle

Formulation de la Politique

Promotion de la recherche

Dveloppement de la production locale

Droits de proprit intellectuelle et savoir mdical traditionnel

Renforcement des capacits

*


Lintgration" de la Mdecine traditionnelle dans les Systmes de Sant des Pays de la Rgion africaine de lOMS (Juin 2006)

Chart1

National policy on TMNational policy on TM22

Legal framework for TM practiceLegal framework for TM practice13

Code of Ethics for THPsCode of Ethics for THPs9

Strategic plan for Dev. of TMStrategic plan for Dev. of TM8

Regulations on TMRegulations on TM17

TRM Office in MOHTRM Office in MOH29

TRM Programme in MOHTRM Programme in MOH21

Expert Committee on TMExpert Committee on TM20

Some Elements for "Integration"

Number of Countries

Sheet1

National policy on TM22

Legal framework for TM practice13

Code of Ethics for THPs9

Strategic plan for Dev. of TM8

Regulations on TM17

TRM Office in MOH29

TRM Programme in MOH21

Expert Committee on TM20

Sheet1

000

000

000

000

000

000

000

000

Some Elements for "Integration"

Number of Countries

"Integration" of TM in Health Systems of Countries in WHO/AFRO Region (June 2006)

Sheet2

Sheet3


Pays conduisant des recherches sur les maladies prioritaires

Chart1

HIV/AIDS15

Malaria12

Diabetes9

Hypertension8

Sickle cella anaemia4

Maladies prioritaires retenues par le Bureau rgional

Number of countries

Sheet1

HIV/AIDS15

Malaria12

Diabetes9

Hypertension8

Sickle cella anaemia4

Sheet1

Diseases selected by WHO/AFRO

Number of countries

Countries conducting research in the WHO/AFRO Region

Sheet2

Sheet3

Diseases selected by WHO/AFRO

Number of countries

Countries conducting research in WHO/AFRO Region


Pays ayant labor une politique de Mdecine traditionnelle au cours de la priode 2001-2007


*Priority interventions (1)Policy Formulation and legal framework Regional Level:Guidelines for the Formulation and Implementation of National Traditional Medicine Policies.Model Legal Framework for the Practice of Traditional MedicineModel Code of Ethics for Traditional Health Practitioners.Institution of the African Traditional Medicine Day on 31 August of each year (commemorated at regional and country level).And support provided to countries which have requested and expressed need (technical and/or financial) for activities related to institutionalization of TM in health systems.


Pays ayant dvelopp un cadre juridique pour la pratique de la Mdecine traditionnelle au cours de la priode 2001-2007


*Priority interventions (1): Country level (2001-2007)

National Policy on TM (N = 20) Legal framework for the practice (N = 18) Code of Ethics for THPs (N = 13) Strategic plan on TM (N = 12) Benin*, Cameroon, CAR, Chad, Congo, Cte dIvoire, DRC, Gambia, Ghana, Kenya, Malawi, Mali, Mozambique, Nigeria, Uganda, Rwanda, Sierra Leone, Tanzania, Zambia, Zimbabwe. Burkina Faso, Cameroon, CAR, Chad, Congo, DRC, Ghana, Kenya, Madagascar, Malawi, Namibia, Nigeria, Rwanda, Senegal, Sierra Leone, Tanzania, Zambia. Cameroon, CAR, Chad, Congo, DRC, Ghana, Kenya, Rwanda, Sierra Leone, Tanzania, Uganda, Zambia, Zimbabwe. Cameroon, Chad, Congo, DRC, Gambia, Ghana, Guinea, Mali, Nigeria, Rwanda, Senegal, Tanzania.


Pays ayant labor un Code national dthique et de pratiques pour les tradipraticiens au cours de la priode 2001-2007


*Priority interventions (2)Capacity buildingRegional level:Development and support of Field-testing of the WHO Training Tools for THPs in PHC and for Health science students and CHPs in Traditional medicine.

Organization in collaboration with TDR/HQ of Training on Non Clinical Safety Testing (in Johannesburg) followed by an Experience sharing workshop on research [pre-clinical and clinical studies] (in Nairobi).


*Priority interventions (2)Capacity buildingCountry level: Ten countries field-tested WHO Training tools in PHC for THPs and in TM Health sciences students (Cameroon, Congo, DRC, Ghana, Kenya, Mali, Senegal, South Africa, Tanzania, Uganda).

Before field-testing WHO Training tools, some countries have already their own curricula and sessions of training for THPs, pharmacists, nurses and medical doctor: Benin, Burkina Faso, Congo, Ghana, Ethiopia, Mali, Mozambique, Nigeria, Uganda, Zambia, Zimbabwe.


*Priority interventions (3)Research promotionRegional Level:Development of Guidelines for clinical study for the management of the 5 priority diseases (HIV/AIDS, Malaria, Sickle cell anaemia, Diabetes and High blood pressure).

Supports (financial and technical) provided to countries undertaking ethnobotanic studies, pre-clinical and clinical study for assessment of Safety, efficacy and quality of TMs for the management of the above-mentioned diseases.


*Priority interventions (3): Country level

CountryMalariaHIV/AIDSSCADiabetesHBPBeninxxxxBurkina FasoxxxBurundixCte dIvoirexxDRCxxEthiopiaxxGhanaxxxxKenyaxxxMadagascarxxxMalixxxx



CountryMalariaHIV/AIDSSCADiabetesHBPMozambiquexNigeriaxxxxxSenegalxSouth africaxxxxTanzaniaxxxTogo xxUgandaxZambiaxZimbabwexx



MalariaHIV/AIDSSCADiabetesHBPNumber of countries1414488


*Priority interventions (4)Development of local production of TMs

Regional Level:Strategic plan for strengthening local production capacity of traditional medicines (2006 2010).Guidelines for registration of traditional medicines in WHO AFRO region.

Country level: Situation analysis and Needs assessment on local production of Traditional medicines.Support provided to countries to establish and strengthen MRA.Small Scale of production of TMs: Burkina Faso, Cameroon, DRC, Gabon, Gambia, Ghana, Madagascar, Mali, Mauritania, Niger, Nigeria, Rwanda, Senegal, Seychelles, Zimbabwe.Delivery of Marketing Authorizations.Feasibility study for domestic production of dihydroartemisinin for treatment of uncomplicated Pl. falciparum malaria.Cultivation of commonly used medicinal plants for local production:


*Priority interventions (5)Protection of TMK and IPRs related to Traditional medicineRegional Level:Development of tool for documenting African Traditional Medicine.

Development of Guidelines on national policy for the protection of indigenous and traditional medical knowledge and regulation of access to biological resources in WHO African Region.Draft WHO Model legislation for the protection and promotion of Traditional medical knowledge and access to biological resources in WHO African Region.

Country level: Workshops and meetings organized at country level to strengthen local capacity and framework on the protection of TMK and IPRs in some countries (Ghana, Tanzania, .)


LE LOGO DE LA MEDECINE TRADITIONNELLE AFRICAINE

Merci de votre attention

***In 1978, the Alma Ata declaration recognized the role of traditional medicine and its practitioners as important actors for achieving health for All. Since then the WHO Governing bodies at regional and global levels and partners have made recommendations and adopted various resolutions on traditional medicine. These include on: -Legislation-Use of pharmacopoeia-Research-Development of local production-Use of traditional medicines2. In 2000, the fiftieth session of the Regional Committee for Africa, in Ouagadougou, adopted a resolution on Promoting the role of traditional medicine in health systems. This is now the basis for supporting Member states to develop TM in terms of priority interventions. 3. A year later, 2001 in Abuja, the African Union Heads of States and Government declared that research on TMs for Malaria, HIV/AIDS, TB and Other Priority Diseases should be made a priority4. The same year, 2001 in Lusaka, they declared the period 2001-2010 as the decade for African Traditional medicine.

*2000 - la Rsolution AFR/RC50/R3 de lOMS relative la promotion du rle de la MT dans le systme de sant: Stratgie de la Rgion africaine. Ce document est comme une bible de la Mdecine traditionnelle (MT)

2001 - la Dclaration du Sommet des Chefs dtat Abuja sur la recherche de la MT pour le traitement du Paludisme, VIH/SIDA, TB et autres maladies infectieuses comme prioritaire (Avril)

2001 - la Dclaration du Sommet des Chefs dtat Lusaka dsignant la priode 2001-2010: Dcennie de la MT africaine (juillet)

2002 - la Dsignation par lOMS de la journe du 31 aot de chaque anne comme Journe Africaine de la MT et approbation par les Chefs dtat Maputo 2003*In 1978, the Alma Ata declaration recognized the role of traditional medicine and its practitioners as important actors for achieving health for All. Since then the WHO Governing bodies at regional and global levels and partners have made recommendations and adopted various resolutions on traditional medicine. These include on: -Legislation-Use of pharmacopoeia-Research-Development of local production-Use of traditional medicinesIn 2000, the fiftieth session of the Regional Committee for Africa, in Ouagadougou, adopted a resolution on Promoting the role of traditional medicine in health systems. This is now the basis for supporting Member states to develop TM in terms of priority interventions. A year later, 2001 in Abuja, the African Union Heads of States and Government declared that research on TMs for Malaria, HIV/AIDS, TB and Other Priority Diseases should be made a priorityThe same year, 2001 in Lusaka, they declared the period 2001-2010 as the decade for African Traditional medicine.

*The Fiftieth Session of the WHO Regional Committee for Africa adopted the Regional Strategy on Promoting the Role of Traditional Medicine in Health Systems which has for priority interventions:Policy formulation where countries are urged to develop tools for institutionalizing TM in health systems Capacity building Where countries are expected to build capacities in all aspects of TMResearch promotion Countries are urged to conduct relevant research to produce evidence on safety, efficacy and quality of TMs

Development of local production and conservation of medicinal plants Countries are urged to create an enabling political, regulatory and economic environment for LP of TMs and to cultivate large-scale of medicinal plants

Protection of intellectual property rights (IPRs) and traditional medical knowledge countries are encouraged to develop/update legislation for protection of IPRs and indigenous knowledge.*

A number of countries are at different stages of research and development using WHO Protocols. Here you can give an example of your own research.

The ability to conduct research and the tools and guidelines do exist. However, there is need to build the culture for research in the Region.

*

A number of countries are at different stages of research and development using WHO Protocols. Here you can give an example of your own research.

The ability to conduct research and the tools and guidelines do exist. However, there is need to build the culture for research in the Region.

**Country level:

Many Member states in the WHO african region have been institutionalizing TM in health system.

*Modules for training health science students and conventional health practitioners in traditional medicine reviewed and adopted.The training tool on primary health care for continuing education of traditional health practitioners reviewed and adopted.Training Modules for Doctors - Ghana and Zimbabwe ..

Training Modules for Pharmacists- Burkina Faso, Cte dIvoire, Ghana, Mali, Nigeria and Zimbabwe.

Training Modules for Traditional health practitiones- Botswana, Cte dIvoire, Gambia, Guine, Senegal, and Zambia . . .

Training Modules for Nurses - Ethiopia, Ghana, Zimbabwe

Training Modules for Traditional Birth Attendants - Cap Verde, Cte dIvoire, Equatorial Guinea, Eritrea, Gambia, Ghana, Guinea Bissau, Lesotho, Malawi, Mauritania, Mozambique, Niger, Nigeria, Rwanda, Sao Tom et Principe, Zambia, Zimbabwe

*For the five identified as priority disease, the following countries indicated that they were conducting pre-clinical and/or clinical evaluation of traditional herbal medicines used for the managementof Malaria: Burkina Faso, DRC, Ghana, Kenya, Madagascar, Mali, Nigeria, Tanzania and Zimbabwe; for HIV/AIDS: Benin, Burkina Faso, DRC, Ghana, Cote dIvoire, Kenya, Mali, Nigeria, South Africa, Tanzania, Togo, Uganda and Zimbabwe; for diabetes: Benin, Burundi, Ghana, Madagascar, Mali, Nigeria and Tanzania; for sickle-cell anaemia: Burkina Faso, Togo and Nigeria, and for hypertension: Cote dIvoire, Ghana, Kenya, Madagascar and Mali. *Cest le Logo de la Mdecine traditionnelle africaine.Je voudrais souligne et vous rappeler que la Mdecine traditionnelle cest notre culture, notre patrimoire et notre avenir. Si nous les africains nous ne pensons pas la dvelopper, personne dautre ne viendra pas notre place pour le faire. La plante dans la carte de lAfrique - est dorigine du Madagascar (periwinkle, cantharanthus roseus) avec le quelle la vinblastine et la vincristine qui sont mdicament essentielle pour le traitement du cancer sont fabriquer et explique la source du matire de base pour les remdes traditionnels La carte de lAfrique vert explique lappropriation de la Mdecine traditionnelle Leau auntorn de la carte unaltre source du matire de base pour les remdes traditionnels Bord dor/Contour en or explique la biodiversit de lAfrique et lavantage comparative de lAfrique par rapport autre continent.*

Vive lorganisation Mondiale de la Proppriete Intellectuelle (lOMPI)Vive la rpublique du MaliVive le department du Mdecine Traditionnelle

Documents

Etat de mise en œuvre de la Stratégie régionale pour la promotion de la Médicine traditionnelle E